These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 22614520)

  • 21. Chagasic meningoencephalitis with detection of Trypanosoma cruzi in the cerebrospinal fluid of an immunodepressed patient.
    Jardim E; Takayanagui OM
    J Trop Med Hyg; 1994 Dec; 97(6):367-70. PubMed ID: 7966540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunosuppression and Chagas disease: a management challenge.
    Pinazo MJ; Espinosa G; Cortes-Lletget C; Posada Ede J; Aldasoro E; Oliveira I; Muñoz J; Gállego M; Gascon J
    PLoS Negl Trop Dis; 2013; 7(1):e1965. PubMed ID: 23349998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infections in solid organ transplantation in special situations: HIV-infection and immigration.
    Miró JM; Blanes M; Norman F; Martín-Dávila P
    Enferm Infecc Microbiol Clin; 2012 Mar; 30 Suppl 2():76-85. PubMed ID: 22542039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of Trypanosoma cruzi infection in the indeterminate phase: experience and current guidelines in Argentina].
    Sosa Estani S; Segura EL
    Medicina (B Aires); 1999; 59 Suppl 2():166-70. PubMed ID: 10668259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transplantation for chagas' disease: closing the knowledge gap.
    La Hoz RM
    Curr Opin Infect Dis; 2022 Oct; 35(5):397-403. PubMed ID: 35942849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update in treatment of Chagas disease.
    Le Loup G; Pialoux G; Lescure FX
    Curr Opin Infect Dis; 2011 Oct; 24(5):428-34. PubMed ID: 21857512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An approach to the management of Trypanosoma cruzi infection (Chagas' disease) in immunocompromised patients.
    Martinez-Perez A; Norman FF; Monge-Maillo B; Perez-Molina JA; Lopez-Velez R
    Expert Rev Anti Infect Ther; 2014 Mar; 12(3):357-73. PubMed ID: 24484076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chagas Disease Recommendations for Solid-Organ Transplant Recipients and Donors.
    Pierrotti LC; Carvalho NB; Amorin JP; Pascual J; Kotton CN; López-Vélez R
    Transplantation; 2018 Feb; 102(2S Suppl 2):S1-S7. PubMed ID: 29381572
    [No Abstract]   [Full Text] [Related]  

  • 29. Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas' heart disease.
    Bocchi EA; Higuchi ML; Vieira ML; Stolf N; Bellotti G; Fiorelli A; Uip D; Jatene A; Pileggi F
    J Heart Lung Transplant; 1998 Apr; 17(4):399-405. PubMed ID: 9588585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-time PCR in HIV/Trypanosoma cruzi coinfection with and without Chagas disease reactivation: association with HIV viral load and CD4 level.
    de Freitas VL; da Silva SC; Sartori AM; Bezerra RC; Westphalen EV; Molina TD; Teixeira AR; Ibrahim KY; Shikanai-Yasuda MA
    PLoS Negl Trop Dis; 2011 Aug; 5(8):e1277. PubMed ID: 21912712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Donor-derived Trypanosoma cruzi infection in solid organ recipients in the United States, 2001-2011.
    Huprikar S; Bosserman E; Patel G; Moore A; Pinney S; Anyanwu A; Neofytos D; Ketterer D; Striker R; Silveira F; Qvarnstrom Y; Steurer F; Herwaldt B; Montgomery S
    Am J Transplant; 2013 Sep; 13(9):2418-25. PubMed ID: 23837488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is it safe to use a liver graft from a Chagas disease-seropositive donor in a human immunodeficiency virus-positive recipient? A case report addressing a novel challenge in liver transplantation.
    Goldaracena N; Wolf MM; Quiñonez E; Anders M; Mastai R; McCormack L
    Liver Transpl; 2012 Aug; 18(8):979-83. PubMed ID: 22508549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The chemotherapy of Chagas disease].
    Stoppani AO
    Medicina (B Aires); 1999; 59 Suppl 2():147-65. PubMed ID: 10668258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS.
    Sartori AM; Ibrahim KY; Nunes Westphalen EV; Braz LM; Oliveira OC; Gakiya E; Lopes MH; Shikanai-Yasuda MA
    Ann Trop Med Parasitol; 2007 Jan; 101(1):31-50. PubMed ID: 17244408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recognizing and meeting the challenge of Chagas disease in the USA.
    Bowling J; Walter EA
    Expert Rev Anti Infect Ther; 2009 Dec; 7(10):1223-34. PubMed ID: 19968514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Update on the treatment of Chagas' disease].
    Apt W; Zulantay I
    Rev Med Chil; 2011 Feb; 139(2):247-57. PubMed ID: 21773664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chagas' disease reactivation after heart transplantation: efficacy of allopurinol treatment.
    Almeida DR; Carvalho AC; Branco JN; Pereira AP; Correa L; Vianna PV; Buffolo E; Martinez EE
    J Heart Lung Transplant; 1996 Oct; 15(10):988-92. PubMed ID: 8913915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and epidemiological features of chronic Trypanosoma cruzi infection in patients with HIV/AIDS in Buenos Aires, Argentina.
    Benchetrit AG; Fernández M; Bava AJ; Corti M; Porteiro N; Martínez Peralta L
    Int J Infect Dis; 2018 Feb; 67():118-121. PubMed ID: 29196277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Erythema nodoso in reactivation of Chagas' disease after cardiac transplantation].
    d'Avila SC; d'Avila AM; Pagliari C; Gonçalves VM; Duarte MI
    Rev Soc Bras Med Trop; 2005; 38(1):61-3. PubMed ID: 15717098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Part VI. Antiparasitic treatment for Chagas disease].
    B WA; G IH; L MI; M LJ; V PM; H IN; V AM; P JS; H MT; A IZ
    Rev Chilena Infectol; 2008 Oct; 25(5):384-9, discussion 387. PubMed ID: 18949153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.